Clinical Trials Browser

Phase 3 × INDUSTRY × navicixizumab × Clear all

NCT05043402 2022-08-15

A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer

Phase 3 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms